Amendment S.3140

This bill empowers the Health Policy Commission to investigate whether nonprofit hospitals are setting drug prices that are unreasonable or excessive. Upon receiving a referral, the commission can require hospitals to submit detailed information about their pricing methods, including how they calculate markups and how they treat drugs acquired under the 340B program. While the bill mandates the disclosure of specific pricing data, it includes strong confidentiality protections to prevent hospitals from revealing trade secrets or sensitive financial details. If the commission finds a price is too high, it will issue a public report with findings and recommendations, which may then trigger an independent investigation by the Attorney General. Ultimately, the legislation aims to increase transparency in hospital drug pricing without directly mandating specific price reductions.